RxNorm 835726 NDC Crossover
acamprosate calcium 333 MG Delayed Release Oral Tablet
Related NDC Codes to RxNorm Concept 835726
The following NDC codes crossover to the RxNorm Concept 835726. This list is useful when crossing over from a given RxNorm code and the user is trying to choose a drug or product included in the NDC directory.
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Status | |
---|---|---|---|---|---|---|---|
0378-6333 | Acamprosate Calcium | Acamprosate Calcium Enteric-coated | Tablet, Delayed Release | Oral | Mylan Pharmaceuticals Inc. | ACTIVE | |
0904-7213 | Acamprosate Calcium | Acamprosate Calcium | Tablet, Delayed Release | Oral | Major Pharmaceuticals | ACTIVE | |
10135-636 | Acamprosate Calcium | Marlex Pharmaceuticals Inc | INACTIVATED | ||||
60687-121 | Acamprosate Calcium | Acamprosate Calcium | Tablet, Delayed Release | Oral | American Health Packaging | ACTIVE | |
68151-4760 | Campral | Carilion Materials Management | INACTIVATED | ||||
68382-569 | Acamprosate Calcium | Acamprosate Calcium | Tablet, Delayed Release | Oral | Zydus Pharmaceuticals (usa) Inc. | ACTIVE | |
68462-435 | Acamprosate Calcium | Acamprosate Calcium | Tablet, Delayed Release | Oral | Glenmark Pharmaceuticals Inc., Usa | ACTIVE | |
70771-1057 | Acamprosate Calcium | Acamprosate Calcium | Tablet, Delayed Release | Oral | Zydus Lifesciences Limited | ACTIVE |